Clinical Trial

Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the present study is to investigate a) the presence of subclinical markers of vascular, myocardial and endothelial function in women with PCOS b) the acute alterations in these markers during the oral glucose tolerance test (OGTT) c) the impact of potential treatment interventions in these markers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-20.
Trial Details
NCT Number NCT06889454
Lead Sponsor Attikon Hospital
Conditions PCOS, Hyperinsulinism, Hyperandrogenism, Metabolic Syndrome
Enrollment 120 participants
Start Date 2024-02-01
Primary Completion 2025-02-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-19